FL118 Is a Potent Therapeutic Agent against Chronic Myeloid Leukemia Resistant to BCR-ABL Inhibitors through Targeting RNA Helicase DDX5. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.